Dr. Peccoud’s research program combines computational and experimental efforts to develop predictive models of behaviors encoded in DNA sequences. He takes advantage CSU expertise in biomanufacturing to develop a rapid prototyping platform to manufacture biologic drugs, antibodies, and other proteins of commercial interest. Peccoud is also actively engaged in efforts to understand the security implications of synthetic biology.
Shortly after completing a graduate research project in molecular immunology, Jean Peccoud’s scientific interests shifted to computational biology. In 1989, he published one of the first articles describing a mathematical model of molecular noise in gene regulatory networks. In 1993, he recognized the importance of real-time PCR and developed new statistical techniques suitable to analyse this new type of data. In 2002, he observed with excitement the very early developments of synthetic biology. After exploring the potential applications of this new technology to plant biotechnology, he blazed a trail in synthetic biology informatics.
Jean Peccoud came to Colorado State University from the Virginia Bioinformatics Institute at Virginia Tech. He brings with him a diverse experience that includes working for Fortune 500 and start-up companies. He is the founding Editor-in-Chief of the journal Synthetic Biology published by Oxford University Press.